World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
25407
World Ranking
14200
National Ranking
7187

Thomas J. Herzog publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Thomas J. Herzog sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 517 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Thomas J. Herzog D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas J. Herzog sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2008 - Fellow of the American Statistical Association (ASA)

Overview

Thomas J. Herzog is affiliated with the University of Cincinnati in the United States. Their research primarily focuses on medicine, with a significant number of publications in reproductive medicine, oncology, obstetrics and gynecology, surgery, and pulmonary and respiratory medicine.

Their main research topics include ovarian cancer diagnosis and treatment, endometrial and cervical cancer treatments, PARP inhibition in cancer therapy, cancer immunotherapy and biomarkers, intraperitoneal and appendiceal malignancies, cancer genomics and diagnostics, and the economic and financial impacts of cancer.

Notable recent papers authored or co-authored by Thomas J. Herzog include:

  • Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer, 2023, New England Journal of Medicine
  • A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer, 2020, Gynecologic Oncology
  • Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO), 2023, Gynecologic Oncology
  • Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study, 2022, International Journal of Gynecological Cancer
  • The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage, 2021, American Journal of Obstetrics and Gynecology

Frequent publication venues for their work include:

  • Gynecologic Oncology
  • Journal of Clinical Oncology
  • International Journal of Gynecological Cancer
  • American Journal of Obstetrics and Gynecology
  • Gynecologic Oncology Reports

Among their frequent collaborators are:

  • Bradley J. Monk
  • Robert L. Coleman
  • David M. O'Malley
  • Kathleen N. Moore
  • Brian M. Slomovitz

Thomas J. Herzog was awarded the title of Fellow of the American Statistical Association (ASA) in 2008.

Best Publications

  • Nationwide trends in the performance of inpatient hysterectomy in the United States

    Jason D. Wright;Thomas J. Herzog;Jennifer Tsui;Cande V. Ananth

  • Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

    Robert L. Coleman;Mark F. Brady;Thomas J. Herzog;Paul Sabbatini

  • Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease

    Jason D. Wright;Cande V. Ananth;Sharyn N. Lewin;William M. Burke

  • Endometrial cancer: A review and current management strategies: Part I

    William M. Burke;William M. Burke;James Orr;Mario Leitao;Emery Salom

  • Latest research and treatment of advanced-stage epithelial ovarian cancer

    Robert L. Coleman;Bradley J. Monk;Anil K. Sood;Thomas J. Herzog

  • Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

    Bradley J. Monk;Thomas J. Herzog;Stanley B. Kaye;Carolyn N. Krasner

  • Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

    Andreas Du Bois;Anne Floquet;Jae Weon Kim;Jae Weon Kim;Joern Rau

  • Comparative Performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for Uterine Corpus Cancer.

    Sharyn N. Lewin;Jason D. Wright

  • Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer

    Krishnansu S. Tewari;Robert A. Burger;Danielle Enserro;Barbara M. Norquist

  • Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

    Bradley J. Monk;Andrés Poveda;Ignace Vergote;Francesco Raspagliesi

  • Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.

    Johnathan M. Lancaster;C. Bethan Powell;Noah D. Kauff;Ilana Cass

  • Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

    Devansu Tewari;James J. Java;Ritu Salani;Deborah K. Armstrong

  • Contemporary management of endometrial cancer

    Jason D Wright;Nicanor I Barrena Medel;Jalid Sehouli;Keiichi Fujiwara

  • Prognostic significance of adenocarcinoma histology in women with cervical cancer.

    Vijaya Galic;Thomas J. Herzog;Sharyn N. Lewin;Alfred I. Neugut

  • Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

    Robert L. Coleman;Nick M. Spirtos;Danielle Enserro;Thomas J. Herzog

  • Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers

    Paul J. Goodfellow;Barbara M. Buttin;Thomas J. Herzog;Janet S. Rader

  • Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.

    Stacia L. Peiffer;Thomas J. Herzog;Doris J. Tribune;David G. Mutch

  • Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer.

    David E. Cohn;Farrokh Dehdashti;Randall K. Gibb;David G. Mutch

  • Recurrent ovarian cancer: how important is it to treat to disease progression?

    Thomas J. Herzog

  • Robotically Assisted vs Laparoscopic Hysterectomy Among Women With Benign Gynecologic Disease

    Jason D. Wright;Cande V. Anath;Sharyn N. Lewin;William M. Burke

Frequent Co-Authors

Jason D. Wright
Jason D. Wright Columbia University
Bradley J. Monk
Bradley J. Monk University of Arizona
Robert L. Coleman
Robert L. Coleman The University of Texas MD Anderson Cancer Center
Dawn L. Hershman
Dawn L. Hershman Columbia University
Alfred I. Neugut
Alfred I. Neugut Columbia University
Cande V. Ananth
Cande V. Ananth Rutgers, The State University of New Jersey
David G. Mutch
David G. Mutch Washington University in St. Louis
Robert S. Mannel
Robert S. Mannel University of Oklahoma Health Sciences Center
Michael Friedlander
Michael Friedlander University of New South Wales
Kathleen N. Moore
Kathleen N. Moore University of Oklahoma Health Sciences Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

In addition to traditional medical degrees in the USA, students have an array of flexible options through online programs. For those interested in the technology and data side of healthcare, a health information technology online degree teaches skills in managing patient data and information systems, crucial for the digital transformation of healthcare.

If you’re interested in healthcare administration or entry-level medical roles, consider courses focusing on insurance and claims. Many students search for affordable medical billing and coding cost programs to jumpstart a career in this high-demand field.

Nursing remains a sought-after path, and there are many affordable nursing programs available online. For registered nurses who want to advance their practice, cheapest online fnp programs open up opportunities in advanced patient care, often with flexible online study options.

Online degrees in these areas provide accessible routes to stable and rewarding healthcare careers, with options that can suit a range of educational backgrounds and budgets.

Best Scientists Citing Thomas J. Herzog

Trending Scientists

Recently Published Articles